Lo Simpesse Kit
Product Images NDC 65862-866

8 FDA label images from Aurobindo Pharma Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Lo Simpesse (NDC 65862-866). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-1 (Levonorethinyl Fig1)

Figure-1 (Levonorethinyl Fig1)
A bar chart illustrating the percentage of bleeding and/or spotting versus bleeding alone in four cycles over different day ranges for the product Lo Simpesse (levonorgestrel and ethinyl estradiol kit). Each cycle shows values for days ≥7 and days ≥20, with sample sizes noted for each cycle (848 to 574). Percentages decrease through cycles from 76% bleeding and/or spotting in Cycle 1 to 49% in Cycle 4.*
FDA Label Image

Figure2 (Levonorethinyl Fig2)

Figure2 (Levonorethinyl Fig2)
A forest plot chart showing effect estimates comparing Ever COC use versus Never COC use and Current COC use versus Never Use. The chart includes data points, confidence intervals, and risk ratios (RR), odds ratios (OR), and hazard ratios (HR) from multiple studies dated from 2002 to 2017. The x-axis represents the effect estimate ranging from -1.50 to 2.00.*
FDA Label Image

Figure-3 (Levonorethinyl Fig3)

Figure-3 (Levonorethinyl Fig3)
A vertical flow chart depicting the relative effectiveness of birth control methods, starting with 'Fewer pregnancies' at the top and 'More pregnancies' at the bottom. The chart lists methods such as implants, injections, intrauterine devices, and sterilization under 'Fewer pregnancies'; birth control pills, skin patch, and vaginal rings with hormones next; followed by condoms and diaphragm; then no sex during fertile days, spermicide, and withdrawal; and finally, no birth control leading to the most pregnancies.*
FDA Label Image

Package Label-principal Display Panel (0.1 mg/0.02 mg and 0.01 mg (91 Tablets Pouch))

Package Label-principal Display Panel (0.1 mg/0.02 mg and 0.01 mg (91 Tablets Pouch))
Lo Simpesse contraceptive kit contains three illustrated blister card layouts showing weekly medication schedules. Each card displays a grid of empty circles labeled by days of the week from Sunday to Saturday and weeks numbered 1 to 4 or 1 to 5. The cards outline a 28 or 35 day dosage plan. The generic names and strengths Levonorgestrel 0.1 mg, Ethinyl Estradiol 0.02 mg, and Ethinyl Estradiol 0.01 mg are included in fine print beneath each layout.*
FDA Label Image

Package Label-principal Display Panel (0.1 mg/0.02 mg and 0.01 mg (91 Tablets Carton))

Package Label-principal Display Panel (0.1 mg/0.02 mg and 0.01 mg (91 Tablets Carton))
Lo Simpesse kit containing Levonorgestrel and Ethinyl Estradiol tablets USP 0.1 mg/0.02 mg and Ethinyl Estradiol tablets USP 0.01 mg, distributed by Aurobindo Pharma USA, Inc. The label indicates 1 extended-cycle wallet with 91 tablets: 84 light pink tablets containing levonorgestrel and ethinyl estradiol, and 7 light blue tablets containing ethinyl estradiol. Includes storage, usage, and safety information.*
FDA Label Image

Levonorethinyl Fig6

Levonorethinyl Fig6
Lo Simpesse kit packaging label with Levonorgestrel 0.1 mg and Ethinyl Estradiol 0.02 mg plus Ethinyl Estradiol 0.01 mg tablets. The kit contains 2 extended-cycle wallets, each with 91 tablets (84 light pink and 7 light blue). Labeler is Aurobindo Pharma Limited. Includes usage instructions, storage conditions, and warnings. Distributed in the USA and made in India.*
FDA Label Image

Levonorgestrel Chemical Structure (Levonorethinyl Str1)

Levonorgestrel Chemical Structure (Levonorethinyl Str1)
Chemical structure of Levonorgestrel, showing its molecular formula C21H28O2 and molecular weight 312.4. The image is a molecular diagram depicting the arrangement of atoms and bonds in Levonorgestrel.*
FDA Label Image

Ethinyl Estradiol Chemical Structure (Levonorethinyl Str2)

Ethinyl Estradiol Chemical Structure (Levonorethinyl Str2)
Chemical structure of Ethinyl Estradiol. The diagram shows the molecular formula C20H24O2 and the molecular weight of 296.4, illustrating the steroidal framework of this active ingredient used in Lo Simpesse.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.